Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, 814 Siksa-dong, Ilsandong-gu, Goyang-si 10326, Republic of Korea.
Cells. 2024 May 24;13(11):901. doi: 10.3390/cells13110901.
has been implicated in various gastrointestinal disorders, including functional dyspepsia. This study aimed to compare the anti- activity and gastroprotective effects of three typical herbal formulas used for gastrointestinal disorders in Korea: Shihosogan-tang (ST), Yijung-tang (YT), and Pyeongwi-san (PS). Firstly, we assessed the total phenolic and flavonoid contents, as well as the antioxidative capacity. Additionally, we evaluated the antibacterial effect on using an ammonia assay, minimum inhibitory concentration (MIC) test, and the disk agar diffusion method. Furthermore, we examined alterations in the gene expression of tight junction proteins, pro-inflammatory cytokines, and cellular vacuolation using an AGS cell model infected with . While ST exhibited a higher total phenolic content, superior free radical scavenging, and inhibition of compared to YT and PS, YT more evidently inhibited gastric cellular morphological changes such as vacuolation. All formulations significantly ameliorated changes in inflammatory and gastric inflammation-related genes and cellular morphological alterations induced by infection. Overall, the present in vitro study suggests that all three herbal formulas possess potential for ameliorating gastrointestinal disorders, with ST relatively excelling in inhibiting infection and inflammation, while YT potentially shows greater efficacy in directly protecting the gastric mucosa.
已被牵涉到各种胃肠道疾病,包括功能性消化不良。本研究旨在比较三种用于治疗韩国胃肠道疾病的典型草药配方的抗活性和胃保护作用:十全大补汤(ST)、一贯煎(YT)和平胃散(PS)。首先,我们评估了总酚和类黄酮含量以及抗氧化能力。此外,我们还使用氨测定法、最小抑菌浓度(MIC)试验和圆盘琼脂扩散法评估了对的抑菌作用。此外,我们还使用 AGS 细胞模型感染研究了紧密连接蛋白、促炎细胞因子和细胞空泡化的基因表达变化。虽然 ST 表现出较高的总酚含量、更强的自由基清除能力和对的抑制作用,但 YT 更明显地抑制了胃细胞形态的空泡化变化。所有配方均显著改善了由感染引起的炎症和与胃炎症相关基因以及细胞形态改变。总的来说,这项体外研究表明,这三种草药配方都具有改善胃肠道疾病的潜力,其中 ST 相对擅长抑制感染和炎症,而 YT 可能在直接保护胃黏膜方面更有效。
World J Gastroenterol. 2015-4-14
J Microbiol Biotechnol. 2025-3-11
Front Cell Infect Microbiol. 2024
Expert Rev Gastroenterol Hepatol. 2023-1
BMC Gastroenterol. 2021-11-25
Cureus. 2021-5-6
Molecules. 2021-5-1